News

Most recently, Dr Duddu held the position of general manager and vice president of worldwide drug delivery technologies of Cima Labs, a wholly owned subsidiary of Cephalon. Prior

CytRx has recruited its first patient in a Phase 2 proof-of-concept trial in patients with high-risk B-cell chronic lymphocytic leukemia (B-CLL), which is advancing towards the initiation of

Edge’s lead drug NimoGel is a combination of the FDA-approved drug Nimodipine, a calcium channel blocker, and a proprietary biodegradable delivery system designed to be injected delivered directly

Under the terms of the agreement ELITech expects to initially purchase 8,333,334 shares of Corgenix common shares at $0.15 per share. Corgenix and ELITech will co-develop new tests

Amgen has filed with the FDA in mid of May, the biologics license application (BLA) submission which summarises clinical experience from nearly 6,900 patients across 18 clinical studies,

Amira’s entirely new Neuro option contains a comprehensive set of tools for neuroscience research, specifically MR diffusion tensor imaging (DTI) as well as CT and MR brain perfusion

Plethora said that hi-Argenol is a novel formulation of purified natural ingredients designed specifically to maintain and improve male sexual health including erectile function and fertility. hi-Argenol is

Stiefel said that the combination of a topical retinoid and an antibiotic are often recommended for the treatment of acne vulgaris. Veltin gel brings these two drug classes

The transaction is valued at EUR1.7m including cash and stock, plus earn-out consideration of cash and stock with a value of up to EUR1.5m. Kai Lindevall, executive officer